Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa.
Eliciting broadly neutralizing antibodies (bnAb) in cervicovaginal mucus (CVM) represents a promising "first line of defense" strategy to reduce vaginal HIV transmission. However, it remains unclear what levels of bnAb must be present in CVM to effectively reduce infection. We approached t...
Main Authors: | Scott A McKinley, Alex Chen, Feng Shi, Simi Wang, Peter J Mucha, M Gregory Forest, Samuel K Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4072659?pdf=render |
Similar Items
-
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
by: Laura E McCoy, et al.
Published: (2015-08-01) -
Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques.
by: Yvonne Rosenberg, et al.
Published: (2015-01-01) -
Human monoclonal antibodies broadly neutralizing against influenza B virus.
by: Mayo Yasugi, et al.
Published: (2013-02-01) -
A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
by: Zhigang Zhang, et al.
Published: (2021-03-01) -
Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus.
by: Pan Kyeom Kim, et al.
Published: (2017-01-01)